Ivosidenib

Generic Name
Ivosidenib
Brand Names
Tibsovo
Drug Type
Small Molecule
Chemical Formula
C28H22ClF3N6O3
CAS Number
1448347-49-6
Unique Ingredient Identifier
Q2PCN8MAM6
Background

Ivosidenib is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. IDH1 is an enzyme that is often mutated and overexpressed in some cancers, leading to aberrant cell growth and proliferation. Ivosidenib inhibits mutated IDH1, blocking the enzymatic activity and further differentiation of cancer cells.
...

Indication

Ivosidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor approved for use in the US and Europe. It is indicated for the treatment of patients with a susceptible IDH1 mutation with:

Associated Conditions
Acute Myeloid Leukemia, Locally Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma, Refractory Acute Myeloid Leukemia (AML), Relapsed Acute Myelogenous Leukemia (AML)
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath